💾 Data Updated: 2025 HTS Revision 30 • Last updated: November 24, 2025

3004.49.00.60 - Medicaments primarily affecting the eyes, ears or respiratory system

Details

FieldValue
Unit of Quantitykg
General Rate of DutyFree
Special Rate of DutyN/A
Column 2 Rate of Duty25%
Quota QuantityN/A
Additional DutiesN/A

Overview

This HTS category, 3004.49.00.60, specifically covers medicaments that are primarily formulated for therapeutic or prophylactic use and target the eyes, ears, or respiratory system. These are typically dispensed in measured doses or packaged for direct retail sale, aligning with the broader scope of heading 3004 for prepared medicaments. The defining characteristic is the intended physiological effect on these particular organ systems.

To differentiate, this category is distinct from its siblings. While 3004.49.00.10 covers cardiovascular agents, and 3004.49.00.50 addresses dermatological agents and local anesthetics, this subcategory focuses on ailments affecting vision, hearing, or breathing. Furthermore, it differs from 3004.49.00.70, which serves as a general "other" category for alkaloids and their derivatives not specifically assigned to the other subcategories within this group.

As a leaf node, 3004.49.00.60 does not have further subdivisions. Therefore, classification within this code relies on the medicament's primary intended use and the specific physiological systems it is designed to treat. Examples would include ophthalmic drops for treating eye infections, ear drops for alleviating pain or infection, or inhalers and nasal sprays used for managing respiratory conditions like asthma or allergies, provided they contain alkaloids or their derivatives.

Stay Updated

Join our newsletter to get all updates of the harmonized Tariff Schedule.